Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for the Minoxidil topical medication.
Tianshi Group (600535.SH) announced that its wholly-owned subsidiary, Jiangsu Tianshi Liduyi Pharmaceutical Co., Ltd. (referred to as "Jiangsu Liduyi"), has received the Drug Registration Certificate for Minoxidil Topical Solution issued by the National Medical Products Administration.
Tasly Pharmaceutical Group (600535.SH) announced that its wholly-owned subsidiary, Jiangsu Tasly Pharmaceutical Group Deyi Pharmaceuticals Co., Ltd. (referred to as "Jiangsu Deyi"), has received the "Drug Registration Certificate" for minoxidil lotion issued by the National Medical Products Administration.
Related Articles
TECHTRONIC IND (00669) cancelled 300,000 repurchased shares on March 30th.
New Stock News | WANYUANTONG submits application to Hong Kong Stock Exchange
SAI LEISURE (01832) announced its annual performance, with a net loss attributable to shareholders of $16.579 million, a 12.53% decrease year-on-year.
TECHTRONIC IND (00669) cancelled 300,000 repurchased shares on March 30th.
New Stock News | WANYUANTONG submits application to Hong Kong Stock Exchange
SAI LEISURE (01832) announced its annual performance, with a net loss attributable to shareholders of $16.579 million, a 12.53% decrease year-on-year.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
